دورية أكاديمية
Open versus minimally invasive surgery for suspected adrenocortical carcinoma.
| العنوان: | Open versus minimally invasive surgery for suspected adrenocortical carcinoma. |
|---|---|
| المؤلفون: | Buller DM; Division of Urology, UConn Health, Farmington, CT, USA., Hennessey AM; Division of Urology, UConn Health, Farmington, CT, USA., Ristau BT; Division of Urology, UConn Health, Farmington, CT, USA. |
| المصدر: | Translational andrology and urology [Transl Androl Urol] 2021 May; Vol. 10 (5), pp. 2246-2263. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Hong Kong] : AME Pub., 2012- |
| مستخلص: | Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. Although laparoscopy has been widely adopted for management of benign adrenal tumors, minimally invasive surgery for ACC remains controversial. Retrospective analyses, frequently with fewer than one hundred participants, comprise the majority of the literature. High-quality data regarding the optimal surgical approach for ACC are lacking due to the rarity of the disease and the fact that determination of tumor type (e.g., adenoma or carcinoma) is determined after adrenalectomy, since adrenal tumors are generally not biopsied. While the benefits of minimally invasive surgery including lower intra-operative blood loss and decreased hospital length-of-stay have been consistently demonstrated, clinical equipoise for long-term survival and recurrence outcomes between open and minimally invasive adrenalectomy (MIA) remains. This review examines retrospective studies that directly compare patients with ACC who underwent either open or laparoscopic adrenalectomy, and considers these findings in the context of current guideline recommendations for surgical management of ACC. Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2020.01.11). The series “Controversies in Minimally Invasive Urologic Oncology” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare. (2021 Translational Andrology and Urology. All rights reserved.) |
| References: | Langenbecks Arch Surg. 2012 Feb;397(2):195-9. (PMID: 21947510) Eur Urol. 2010 May;57(5):873-8. (PMID: 20137850) World J Surg. 2015 May;39(5):1268-73. (PMID: 25526921) Horm Res. 1999;52(2):97-100. (PMID: 10681640) Ann Surg Oncol. 2002 Jun;9(5):480-5. (PMID: 12052760) Surgery. 2017 Jan;161(1):249-256. (PMID: 27855966) Ann Surg Oncol. 1999 Dec;6(8):719-26. (PMID: 10622498) Endocr Regul. 2009 Jul;43(3):127-35. (PMID: 19817507) J Nucl Med. 2004 Jun;45(6):972-9. (PMID: 15181132) J Natl Cancer Inst. 1998 Apr 15;90(8):606-11. (PMID: 9554443) Ann Surg Oncol. 2016 Apr;23(4):1195-202. (PMID: 26480850) Radiology. 2006 Feb;238(2):578-85. (PMID: 16371582) Curr Opin Oncol. 2015 Jan;27(1):44-9. (PMID: 25390555) J Urol. 2005 Feb;173(2):519-25. (PMID: 15643237) BJU Int. 2017 Mar;119(3):436-443. (PMID: 27488744) Front Endocrinol (Lausanne). 2016 Jul 25;7:99. (PMID: 27504106) AJR Am J Roentgenol. 1998 Jul;171(1):201-4. (PMID: 9648789) Ann Surg Oncol. 2013 May;20(5):1456-61. (PMID: 23184291) J Surg Oncol. 2018 Dec;118(7):1155-1162. (PMID: 30332514) Lancet Oncol. 2004 Dec;5(12):718-26. (PMID: 15581542) Cancer. 2008 Dec 1;113(11):3130-6. (PMID: 18973179) NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25. (PMID: 14768652) Surg Endosc. 2013 Nov;27(11):4026-32. (PMID: 23765427) Surg Endosc. 1999 Jul;13(7):715-7. (PMID: 10384082) J Am Coll Surg. 2006 Mar;202(3):423-30. (PMID: 16500246) Eur J Endocrinol. 2015 Apr;172(4):415-22. (PMID: 25599706) Endocr Relat Cancer. 2007 Mar;14(1):13-28. (PMID: 17395972) Ann Chir. 1998;52(4):364-8. (PMID: 9752471) Arch Surg. 2004 Jan;139(1):46-9. (PMID: 14718275) CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. (PMID: 22237781) J Clin Endocrinol Metab. 2011 Dec;96(12):3775-84. (PMID: 21917861) Surg Endosc. 2008 Feb;22(2):516-21. (PMID: 17704864) Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. (PMID: 22997446) Onco Targets Ther. 2018 Mar 21;11:1625-1632. (PMID: 29606881) Surgery. 2005 Dec;138(6):1078-85; discussion 1085-6. (PMID: 16360394) Arch Surg. 2001 May;136(5):543-9. (PMID: 11343545) J Surg Oncol. 2005 Mar 1;89(3):186-92. (PMID: 15719374) World J Surg. 2002 Aug;26(8):1043-7. (PMID: 12045859) World J Surg. 2001 Jul;25(7):891-7. (PMID: 11572030) Endocr Relat Cancer. 2005 Sep;12(3):667-80. (PMID: 16172199) Radiology. 1999 Jul;212(1):35-41. (PMID: 10405717) Endocr Rev. 2014 Apr;35(2):282-326. (PMID: 24423978) Radiology. 1998 May;207(2):369-75. (PMID: 9577483) J Clin Oncol. 2013 Aug 20;31(24):3012-8. (PMID: 23752102) Horm Res. 1998;50(4):237-42. (PMID: 9838247) Eur Urol. 2010 Oct;58(4):609-15. (PMID: 20580485) J Laparoendosc Adv Surg Tech A. 2009 Apr;19(2):181-9. (PMID: 19216698) Arch Surg. 2002 Aug;137(8):948-51; discussion 952-3. (PMID: 12146996) Br J Surg. 2017 Mar;104(4):358-376. (PMID: 28199015) Ann Surg Oncol. 2010 Jan;17(1):263-70. (PMID: 19851811) Cancer. 2009 Jan 15;115(2):243-50. (PMID: 19025987) Eur J Endocrinol. 2010 Jun;162(6):1147-53. (PMID: 20348273) Curr Opin Urol. 2006 Mar;16(2):47-53. (PMID: 16479203) J Clin Endocrinol Metab. 2006 Jul;91(7):2650-5. (PMID: 16670169) Surgery. 1996 Feb;119(2):161-70. (PMID: 8571201) J Clin Endocrinol Metab. 2010 Sep;95(9):4106-13. (PMID: 20823463) World J Surg. 2010 Jun;34(6):1380-5. (PMID: 20372905) J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. (PMID: 29891520) Surgery. 2012 Dec;152(6):1158-64. (PMID: 23068084) J Clin Endocrinol Metab. 2013 Jul;98(7):2755-64. (PMID: 23609836) Surgery. 1993 Dec;114(6):1120-4; discussion 1124-5. (PMID: 8256217) Acta Oncol. 2013 Nov;52(8):1771-7. (PMID: 23398621) Surgery. 2012 Dec;152(6):1150-7. (PMID: 23158185) Surgery. 2018 Dec;164(6):1325-1329. (PMID: 30266443) Int J Urol. 2012 Aug;19(8):697-708. (PMID: 22462796) Ann R Coll Surg Engl. 2009 Sep;91(6):489-93. (PMID: 19558758) Endocr Relat Cancer. 2007 Sep;14(3):587-99. (PMID: 17914090) Radiology. 2007 Jun;243(3):760-5. (PMID: 17517932) World J Surg. 2013 Jan;37(1):107-12. (PMID: 23001287) Can J Urol. 2013 Oct;20(5):6915-21. (PMID: 24128829) Eur Urol. 2011 Nov;60(5):1055-65. (PMID: 21831516) J Endourol. 2005 Jul-Aug;19(6):702-8; discussion 708-9. (PMID: 16053359) J Am Coll Surg. 2016 Sep;223(3):485-92. (PMID: 27238874) Am J Med Genet C Semin Med Genet. 2010 Aug 15;154C(3):343-54. (PMID: 20803657) Ann Surg Oncol. 2016 Jan;23(1):126-33. (PMID: 26282907) Semin Surg Oncol. 1999 Jun;16(4):293-306. (PMID: 10332775) J Laparoendosc Adv Surg Tech A. 2008 Feb;18(1):42-6. (PMID: 18266573) Eur J Cancer. 2010 Mar;46(4):713-9. (PMID: 20044246) Ann Surg Oncol. 2016 Jan;23(1):134-41. (PMID: 26286195) J Gastrointest Surg. 2017 Feb;21(2):352-362. (PMID: 27770290) Clin Cancer Res. 2010 Nov 1;16(21):5133-41. (PMID: 20978149) Exp Clin Endocrinol Diabetes. 2006 Feb;114(2):45-51. (PMID: 16570232) Clin Radiol. 2012 Jan;67(1):38-46. (PMID: 21783181) J Clin Endocrinol Metab. 2009 May;94(5):1713-22. (PMID: 19190108) N Engl J Med. 2002 Apr 11;346(15):1128-37. (PMID: 11948273) Ann Surg Oncol. 2014 Jan;21(1):284-91. (PMID: 24046101) Medicine (Baltimore). 2016 May;95(21):e3736. (PMID: 27227935) Endocr Pract. 2009 Jul-Aug;15 Suppl 1:1-20. (PMID: 19632967) J Urol. 1997 Jun;157(6):2239. (PMID: 9146626) |
| فهرسة مساهمة: | Keywords: Adrenocortical carcinoma (ACC); adrenalectomy; laparoscopy; robotic surgery; survival outcomes |
| تواريخ الأحداث: | Date Created: 20210623 Latest Revision: 20210624 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC8185676 |
| DOI: | 10.21037/tau.2020.01.11 |
| PMID: | 34159107 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2223-4691 |
|---|---|
| DOI: | 10.21037/tau.2020.01.11 |